Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Clinical Pharmacology in Drug Development
|
February 4, 2025
Bioavailability, Metabolism, and Excretion of [<sup>14</sup>C]-Tazemetostat in Patients With B-Cell Lymphomas or Advanced Solid Tumors
Yingxue Chen, Renli Teng, Julien Ogier
Future Medicinal Chemistry
|
March 24, 2011
Recent advances in the field of nanometric drug carriers
Julien Ogier, Thomas Arnauld, Eric Doris
European Journal of Drug Metabolism and Pharmacokinetics
|
October 7, 2023
The Pharmacokinetic Profile of Palovarotene: An Open-Label Phase I Trial Investigating the Effect of Food and Potential for Drug-Drug Interaction in Healthy Participants
Rose Marino, Louise Dube, Julien Ogier, et al.
Organic & Biomolecular Chemistry
|
August 27, 2009
Poly-6-cationic amphiphilic cyclodextrins designed for gene delivery
Colin Byrne, Florence Sallas, Dilip K Rai, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
December 6, 2011
Drug delivery and imaging with polydiacetylene micelles
Edmond Gravel, Julien Ogier, Thomas Arnauld, et al.
Plos One
|
June 28, 2013
Cationic and PEGylated Amphiphilic Cyclodextrins: Co-Formulation Opportunities for Neuronal Sirna Delivery
Aoife M O'Mahony, Julien Ogier, Raphael Darcy, et al.
European Journal of Drug Metabolism and Pharmacokinetics
|
February 21, 2023
A Pharmacokinetic, Safety, and Tolerability Trial of Palovarotene in Healthy Japanese and Non-Japanese Participants
Louise Dube, Nobuhiko Haga, Donna Grogan, et al.
Clinical Pharmacology in Drug Development
|
May 10, 2025
Effect of Cytochrome P450 3A Inhibition and Induction by Itraconazole and Rifampin on Tazemetostat Pharmacokinetics in Patients With Advanced Malignancies
Yingxue Chen, Renli Teng, Attila Szanto, et al.
Organic & Biomolecular Chemistry
|
May 23, 2012
A click chemistry route to 2-functionalised PEGylated and cationic β-cyclodextrins: co-formulation opportunities for siRNA delivery
Aoife M O'Mahony, Julien Ogier, Stephane Desgranges, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 20, 2018
Tumor Growth Inhibition Modelling Based on Receptor Occupancy and Biomarker Activity of a New Bcl-2 Inhibitor in Mice
Philippe B Pierrillas, Emilie Henin, Julien Ogier, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Clinical Pharmacology in Drug Development
|
February 4, 2025
Bioavailability, Metabolism, and Excretion of [<sup>14</sup>C]-Tazemetostat in Patients With B-Cell Lymphomas or Advanced Solid Tumors
Yingxue Chen, Renli Teng, Julien Ogier
Future Medicinal Chemistry
|
March 24, 2011
Recent advances in the field of nanometric drug carriers
Julien Ogier, Thomas Arnauld, Eric Doris
European Journal of Drug Metabolism and Pharmacokinetics
|
October 7, 2023
The Pharmacokinetic Profile of Palovarotene: An Open-Label Phase I Trial Investigating the Effect of Food and Potential for Drug-Drug Interaction in Healthy Participants
Rose Marino, Louise Dube, Julien Ogier, et al.
Organic & Biomolecular Chemistry
|
August 27, 2009
Poly-6-cationic amphiphilic cyclodextrins designed for gene delivery
Colin Byrne, Florence Sallas, Dilip K Rai, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
December 6, 2011
Drug delivery and imaging with polydiacetylene micelles
Edmond Gravel, Julien Ogier, Thomas Arnauld, et al.
Plos One
|
June 28, 2013
Cationic and PEGylated Amphiphilic Cyclodextrins: Co-Formulation Opportunities for Neuronal Sirna Delivery
Aoife M O'Mahony, Julien Ogier, Raphael Darcy, et al.
European Journal of Drug Metabolism and Pharmacokinetics
|
February 21, 2023
A Pharmacokinetic, Safety, and Tolerability Trial of Palovarotene in Healthy Japanese and Non-Japanese Participants
Louise Dube, Nobuhiko Haga, Donna Grogan, et al.
Clinical Pharmacology in Drug Development
|
May 10, 2025
Effect of Cytochrome P450 3A Inhibition and Induction by Itraconazole and Rifampin on Tazemetostat Pharmacokinetics in Patients With Advanced Malignancies
Yingxue Chen, Renli Teng, Attila Szanto, et al.
Organic & Biomolecular Chemistry
|
May 23, 2012
A click chemistry route to 2-functionalised PEGylated and cationic β-cyclodextrins: co-formulation opportunities for siRNA delivery
Aoife M O'Mahony, Julien Ogier, Stephane Desgranges, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 20, 2018
Tumor Growth Inhibition Modelling Based on Receptor Occupancy and Biomarker Activity of a New Bcl-2 Inhibitor in Mice
Philippe B Pierrillas, Emilie Henin, Julien Ogier, et al.
Page
of 2